Genomic Expression, Inc. is raising up to $1.24M on StartEngine Capital, LLC in convertible note; in its filing revenue was $223K and it had 5 employees (Form C-U, 2025-02-11).
Genomic Expression, Inc. filed a Regulation Crowdfunding offering with the SEC through StartEngine Capital, LLC, with a target of $15K and a maximum of $1.24M. As of November 6, 2026, the offering is past its deadline of February 6, 2025. The company gives its address as Beverly, MA (Form C/A, December 6, 2024).
Sell to companies like Genomic Expression, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · What it is: Progress update · C-U
- · Intermediary: StartEngine Capital, LLC · Target: $15K · Maximum: $1.24M · Deadline: 2025-02-06 · Security: Convertible Note · C/A
- · What it is: Annual report · C-AR
- · Intermediary: StartEngine Capital, LLC · Target: $15K · Maximum: $1.24M · Deadline: 2025-01-06 · Security: Convertible Note · C/A
- · Intermediary: StartEngine Capital, LLC · Target: $15K · Maximum: $1.24M · Deadline: 2024-10-28 · Security: Convertible Note · C
Genomic Expression, Inc., based in Beverly, MA, filed 3 Regulation Crowdfunding offering filings with the SEC, the latest on 2024-12-06, raising through StartEngine Capital, LLC. It set a target of $15K and will accept up to $1.24M. The security offered is convertible note. As of its filings the offering is past its deadline of 2025-02-06. 5 filings in this family are on record for the company.
Terms at a glance
| Target | $15K |
| Maximum it will accept | $1.24M |
| Security | Convertible Note |
| Units at the target | 15,000 |
| Raise above the target | accepted, other |
| Deadline | 2025-02-06 |
| Raising through | StartEngine Capital, LLC |
| What the portal is paid, as filed | 7 - 13 percent |
Check before you invest in Genomic Expression, Inc.: who signed the filing and its own figures, free.
Free to see. No signup.
Want the whole picture on Genomic Expression, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Genomic Expression, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Genomic Expression, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
5 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
The filing does not state a company valuation or a minimum investment; the offering page on StartEngine Capital, LLC shows those. Check both before you invest.
Offering filings
| Filed | Intermediary | Target | Maximum | Deadline | Security | Filing |
|---|---|---|---|---|---|---|
| 2024-12-06 | StartEngine Capital, LLC | $15K | $1.24M | 2025-02-06 | Convertible Note | C/A |
| 2024-10-16 | StartEngine Capital, LLC | $15K | $1.24M | 2025-01-06 | Convertible Note | C/A |
| 2024-10-01 | StartEngine Capital, LLC | $15K | $1.24M | 2024-10-28 | Convertible Note | C |
Financials the company filed
Figures from the C-U filed 2025-02-11, as the company reported them.
| As filed | Most recent fiscal year | Prior fiscal year |
|---|---|---|
| Revenue | $223K | $608K |
| Net income | -$274K | -$127K |
| Total assets | $1.02M | $1.08M |
| Cash and equivalents | $61K | |
| Short-term debt | $288K | |
| Long-term debt | $473K |
Employees at filing: 5.
Revenue went from $608K to $223K (-63%). Net loss was $274K, against a loss of $127K the year before. It reported $61K in cash and $761K in debt. These are the company's own figures from the Form C-U filed 2025-02-11.
Progress updates
2025-02-11, C-U:
The issuer closed on $125,031.53.
People who signed the filing
- Gitte Pedersen, CEO, Principal Accounting Officer, and Chairman of the Board
- Kirsten Dinesen, Director
- Dr. Morten Lorentz Pedersen, Director, CSO and Co-Founder
Every filing
| Filed | What it is | Filing |
|---|---|---|
| 2025-02-11 | Progress update | C-U |
| 2024-12-06 | Offering amended | C/A |
| 2024-10-18 | Annual report | C-AR |
| 2024-10-16 | Offering amended | C/A |
| 2024-10-01 | Offering | C |
What to check before investing
- Read the offering page on StartEngine Capital, LLC: it states the valuation or cap and the minimum investment, which the SEC filing does not.
- Compare the terms above with the numbers: what does the price imply against revenue of $223K?
- Look at who signed the filing and what else they have run (the founder Snapshot below).
- Check the deadline and what happens if the target is missed.
- You cannot easily sell a crowdfunding security; invest only what you can leave tied up.
A crowdfunding round is won in public. FoxPlug turns your commits, deploys and releases into the posts and visuals that keep the story moving while the offering is open.
Build your launch kitRun a Snapshot on Gitte Pedersen: other companies, roles and the record behind them. Order Full Report from there if you need more.
Snapshot the foundersTools for this story
Each opens in a new tab, filled in for Genomic Expression, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A company raising money from the public under Regulation Crowdfunding has to file with the SEC before the offering opens, and has to raise through a single registered intermediary: a funding portal or a broker-dealer. The first filing, Form C, states how much the company is trying to raise, the most it will accept, the deadline, the security and its price, the intermediary and what the intermediary is paid, and two years of the company's own financial figures.
After that the company files amendments when terms change, progress updates as the raise moves, and an annual report each year until it stops reporting. Every row here is one of those filings, linked to the filing itself, so each figure can be checked at the source. Figures are exactly as the company filed them; where a filing leaves a field blank, so does this page. Nothing here is investment advice, and a filing is the company's own statement, not a verification of it.